Advil Congestion Relief + Advil Allergy and Congestion Relief + Paracetamol
Phase 3Withdrawn 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Common Cold
Conditions
Common Cold
Trial Timeline
Apr 1, 2016 → Nov 1, 2016
NCT ID
NCT01938144About Advil Congestion Relief + Advil Allergy and Congestion Relief + Paracetamol
Advil Congestion Relief + Advil Allergy and Congestion Relief + Paracetamol is a phase 3 stage product being developed by Pfizer for Common Cold. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT01938144. Target conditions include Common Cold.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01938144 | Phase 3 | Withdrawn |
Competing Products
20 competing products in Common Cold